Vitafoods Europe 2024: Bart launches new iron supplement Liposovit-Fe
12 Jun 2024 | Bart
Bart, the Polish producer of natural colors, flavors, emulsions and liposomal vitamins, launched its new Liposovit-Fe iron product at Vitafoods Europe 2024. There, we spoke to the company’s CEO Piotr Pietruszynski, who outlined how the liposomal iron (bisglycinate) supplement in powder form stands out from similar products on the market. He touches upon how the product tackles the issue of iron absorption by the human body, as well as the taste and scientific backing behind the supplement. Pietruszynski asserts that serving a “small dose with high efficiency” is how Liposovit-Fe addresses key market trends.
This is Yolande van Gaal from Nutrition Insights.
I'm here at Widi Food 2024 with Petr Petrosinski, who is the CEO of.
Welcome.
Thank you for joining us today.
Can you tell us, because I know you're launching a new product at, Liposov.
What can you tell us about it?
The Liposov brand name we created 7 years ago.
Last 5 years we launched new products from this range of the Liposoviet brand names starting from vitamin C, from magnesium, and the last launch is Liposoviet iron, which is the liposoviet version of iron.
OK, and how does this compare to other iron supplements that are on the market?
We see that there is a problem with the absorption of the iron by the human body, so our target is to first give the better absorption of the iron to the human body.
Secondly, to minimize the side effects of the iron itself.
Then we focus on the pleasant taste for our customers.
The last, we want to deliver all the scientific background to our customers to convince them that our product is really working, so we do the in vitro trials, clinical trials, and a few of them are already pending to prove and convince the customers about the efficiency.
The iron, but not only all of the Liposoviet brand name products.
What market trends have you noticed and how do your products address them?
Yes, we observe every day that all of us are consuming a lot of different supplements, so our target is to deliver the customers.
Less quantity of the supplements, less active ingredients, but the high efficiency.
But we observed the trend which we can say consume less, but efficiency is much higher.
The other aspect is the new dosage formats for our supplements for the raw materials.
Our target is to have not only stability test the stability data for our raw materials, but also final dosage forms, new ones like gummies, like sachets, like liquid formats.
I think that's the big challenge for companies like us.
And over the next few years, what would you say will be your main focus areas?
We are increasing portfolio of our liposomal products as we did for the last few years.
We work with the big brands on the very sophisticated ingredients.
We have to educate all the people about the good quality of supplements.
Materials.
That's our target.
The last one is again scientific background, information to the customer, clinical trials.
That's our target for the next few years.
OK, awesome.
And can you tell us anything about future plans for product development, expansion into new markets, or what do you expect from the Currently we are proud that we are almost 60 countries worldwide.
And this is a lot of work with our domestic customers with the partners who respect local requirements of the products.
So we want to be more outside Europe, outside Asia, US, and South America, which is a big challenge for us.
Also, we want to create the next level of ingredients which are combination with the liposomal and new technologies.
We are already thinking what will be in the next 5 years on our list.
For this year we will launch new products like liposomal collagen which are big expectations from our customers.
Awesome, I look forward to that.
Thank you so much.
Thank you very much.
